• Public & Media Relations
• Upstate News Home
• About This Office
• Today's Calendar
• Photo Gallery
• News Archives
• Publications
• Physician's Practice
• UpstateOnline
• Upstate Health
• Freedom of Information
• Upstate Social Media
• Public Affairs & Communications Home

News from Upstate

Share

Upstate researcher recognized for work in schizophrenia

SYRACUSE, N.Y. — Upstate Medical University Professor Stephen Glatt, Ph.D., has received the Sidney R. Baer Jr. Prize for Schizophrenia Research from NARSAD in recognition of his work to establish schizophrenia biomarkers that will help doctors identify schizophrenia, intervene earlier for improved treatment and eventually prevent the illness from occurring. The Baer prize is given annually to recognize accomplishments in schizophrenia research.

In addition to his faculty appointment, Glatt serves as associate director of the Medical Genetics Research Center and director of the Psychiatric Genetic Epidemiology and Neurobiology Laboratory at Upstate.

“In perhaps Dr. Glatt’s most impressive work to date, he evaluated brain and blood gene expression levels in individuals with schizophrenia to identify novel candidate genes and putative biomarkers for the disorder,” said Dr. Ming Tsuang of the University of California, San Diego, and NARSAD Scientific Council member who selected this year’s Baer prize winner.

In research centered on the genetic and environmental contributors to major mental illnesses, Glatt is examining candidate genes and conducting genome-wide studies. He is seeking causes and biomarkers that will facilitate earlier identification, intervention and prevention of schizophrenia, bipolar disorder, autism, attention-deficit/hyperactivity disorder and substance abuse. His research has been funded with two NARSAD Young Investigator awards.

NARSAD is the leading donor-supported organization dedicated to finding the causes, improved treatments and cures for mental illness.